The Translational Research Committee is a team of established investigators dedicated to further expanding translational research in USC Stem Cell laboratories. This committee provides investigators with guidance in the translation of their research findings to promote clinical translation and to accelerate the advancement of regenerative medicine.
Committee Members
J. Harold and Edna LaBriola Chair in Genetic Orthopedic Research; Vice Chair for Research, Orthopaedic Surgery; Professor, Orthopaedic Surgery, Stem Cell Biology and Regenerative MedicineThe Evseenko Lab research program is designed to form a bridge between basic studies of early embryogenesis, stem cell biology, and the clinically relevant application of stem cell and small molecule-based therapies for degenerative joint disease known as osteoarthritis as well as chronic inflammatory autoimmune diseases of the joint such as rheumatoid arthritis.
University Professor and George and MaryLou Boone Chair in Craniofacial Molecular Biology; University Professor, Stem Cell Biology and Regenerative Medicine; Director, Center for Craniofacial Molecular Biology; Associate Dean of Research, Ostrow School of Dentistry of USCDr. Chai’s laboratory is interested in early craniofacial development and malformations, including the molecular regulation of cranial neural crest cells. His laboratory has developed genetically engineered mouse models, and has made important discoveries about the mesenchymal stem cell (MSC) niche in the craniofacial region and about utilizing MSCs with 3D printed scaffolds for tissue regeneration.
Director, Translational and Collaborative Research ProgramsDr. Glaeser’s mission is to accelerate and expand USC’s research and therapeutic pipeline in regenerative medicine through the acquisition of public and private programmatic funding, facilitation and oversight of collaborative initiatives, and strategic liaison with complementary partnerships at USC and beyond.
John Douglas French Alzheimer’s Foundation Associate Professor of Stem Cell Biology and Regenerative MedicineDr. Ichida’s research focuses on how genetic and environmental factors contribute to human neurodegenerative disease. His laboratory uses cellular reprogramming and stem cell technology to build patient-specific in vitro models of neurodegenerative disease, enabling the screening of drug-like compounds in search of potential therapeutics.
Areas of support
- Initial consultation on clinical needs and proposed solutions
- Advice on possible funding mechanisms for translational research projects
- Review of specific aims and milestones
- Guidance in identifying key personnel, staffing needs and USC support teams
For more information about the USC Stem Cell Translational Research Committee, please contact Dr. Juliane Glaeser at juliane.glaeser@med.usc.edu.